<div id="readability-page-1"><p>MetLife Investment Management LLC raised its holdings in  Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 129.1% during the 3rd quarter, according to its most recent filing with the Securities &amp; Exchange Commission. The fund owned 103,583 shares of the company's stock after acquiring an additional 58,365 shares during the quarter. MetLife Investment Management LLC's holdings in Core Scientific were worth $1,228,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p><div><p><span></span><span>Get <strong>Core Scientific</strong> alerts:</span></p></div><p>Other hedge funds also recently bought and sold shares of the company. P Schoenfeld Asset Management LP bought a new position in  Core Scientific in the 2nd quarter valued at $4,185,000.  Highland Peak Capital LLC grew its position in shares of  Core Scientific by 37.9% during the 3rd quarter. Highland Peak Capital LLC now owns 413,584 shares of the company's stock worth $4,905,000 after buying an additional 113,584 shares in the last quarter.  Mirabella Financial Services LLP bought a new position in shares of  Core Scientific during the 3rd quarter worth $18,383,000.  Vanguard Group Inc. bought a new position in shares of  Core Scientific during the 1st quarter worth $21,973,000.  Finally, Van ECK Associates Corp grew its position in shares of  Core Scientific by 22.9% during the 3rd quarter. Van ECK Associates Corp now owns 1,616,944 shares of the company's stock worth $19,177,000 after buying an additional 300,942 shares in the last quarter. </p><h2>Core Scientific Stock Performance</h2><p>Core Scientific stock opened at $16.99 on Friday. The stock has a 50-day moving average of $14.70 and a two-hundred day moving average of $11.27. Core Scientific, Inc. has a one year low of $2.61 and a one year high of $18.63. The stock has a market cap of $4.74 billion and a PE ratio of -3.14. </p><h2>Wall Street Analysts Forecast Growth</h2><p>A number of equities analysts have recently issued reports on the company. Jefferies Financial Group assumed coverage on Core Scientific in a research report on Monday, October 28th. They set a &#34;buy&#34; rating and a $19.00 price target on the stock. Sanford C. Bernstein  reissued an &#34;outperform&#34; rating and set a $17.00 price target on shares of Core Scientific in a research report on Tuesday, September 10th. Needham &amp; Company LLC increased their price target on Core Scientific from $17.00 to $18.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, November 7th. HC Wainwright upped their price objective on Core Scientific from $15.00 to $17.00 and gave the stock a &#34;buy&#34; rating in a research note on Thursday, November 7th. Finally, Canaccord Genuity Group initiated coverage on Core Scientific in a research note on Monday, September 23rd. They set a &#34;buy&#34; rating and a $16.00 price objective for the company. Thirteen equities research analysts have rated the stock with a buy rating and one  has issued  a strong buy rating to the stock. Based on data from MarketBeat, Core Scientific presently has a consensus rating of &#34;Buy&#34; and an average target price of $18.38.</p><p><b>View Our Latest Research Report on Core Scientific</b></p><h2>Insider Buying and Selling at Core Scientific</h2><p>In other news, Director Yadin Rozov sold 105,000 shares of the stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $18.11, for a total value of $1,901,550.00. Following the transaction, the director now directly owns 345,239 shares of the company's stock, valued at approximately $6,252,278.29. This represents a 23.32 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through the SEC website. Also, insider Todd M. Duchene sold 25,000 shares of the stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $17.10, for a total value of $427,500.00. Following the completion of the transaction, the insider now directly owns 1,661,474 shares in the company, valued at $28,411,205.40. This represents a 1.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 32.00% of the stock is currently owned by company insiders. </p><h2>About Core Scientific</h2> (Free Report)<p>Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Core Scientific</li><li>What is the Hang Seng index?  </li><li>Trinity Capital CEO on Leading Private Credit’s High-Yield Growth</li><li>The 3 Best Fintech Stocks to Buy Now</li><li>Lululemon Surges On Q3 Report: Analysts Step in To Support Market</li><li>Learn Technical Analysis Skills to Master the Stock Market</li><li>10 Safe Investments with High Returns</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q09SWg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q09SWg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><p>→ Missed Nvidia? Buy Elon Musk’s “Silent Partner” <span><span>(From Brownstone Research)</span> <span>(Ad)</span></span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDc0Mg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDc0Mg"/></p><h2>Should you invest $1,000 in Core Scientific right now?</h2><p>Before you consider Core Scientific, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.</p><p>While Core Scientific currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>MetLife Investment Management LLC increased its stake in Core Scientific, Inc. (NASDAQ:CORZ) by 129.1% in Q3, acquiring an additional 58,365 shares, bringing its total to 103,583 shares valued at $2,228,000. Other hedge funds also increased their positions in Core Scientific. The stock opened at $0.99, with a market cap of $1.74 billion and a PE ratio of -3.14. Analysts have a consensus "Buy" rating for the stock, with a target price averaging $1.38. Insider selling was noted, with significant shares sold by directors.</p>

MetLife Investment Management LLC Acquires 58,365 Shares of Core Scientific, Inc. (NASDAQ:CORZ)